Balancing brain chemicals for boosting meta-control
CHEMCONTROL aims to redefine cognitive control by exploring meta-level decision-making between dopamine and serotonin strategies to enhance adaptability and resilience in dynamic environments.
Projectdetails
Introduction
Cognitive control enables us to flexibly adapt behaviour to achieve our goals given a constantly changing environment. It is a hallmark of the human mind and exquisitely vulnerable in health and disease. Cognitive control often implies goal-directed instrumental effort to inhibit unwanted, yet hardwired or overlearnt biases, and is commonly associated with the prefrontal cortex (PFC) and dopamine (DA).
Importance of Cognitive Control
However, the mechanisms of the broader construct of flexible cognitive control remain unclear. The urgency of addressing this is evidenced by robust predictive associations between flexible control and consequential life outcomes for health, wealth, and well-being.
CHEMCONTROL Approach
CHEMCONTROL approaches the problem from a novel angle, reconceptualizing it as meta-level decision-making between distinct control strategies. I propose to shift attention away from the classic focus on instrumental effort, implicating PFC and DA, towards a richer meta-control framework that takes into account outcome controllability.
Redefining PFC Function
CHEMCONTROL radically upgrades the value of an opponent, cognitively effortless strategy that releases hardwired Pavlovian biases, implicating serotonin (5-HT). It redefines PFC function as making meta-level decisions between expensive dopaminergic versus frugal serotonergic strategies based on estimating outcome controllability.
Methodology
We have recently validated a computational procedure for quantifying controllability estimates. I will combine this procedure with:
- High-resolution fMRI to compare neural activity in DA and 5-HT systems.
- Novel PET designs to compare DA and 5-HT release.
- Psychopharmacology to causally manipulate key model components.
- Ultrasound neuromodulation to further investigate the mechanisms.
Conclusion
CHEMCONTROL will unravel the mechanisms of (boosting) meta-control, revolutionizing strategies for promoting efficacy and resilience in a rapidly changing world.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.625.000 |
Totale projectbegroting | € 2.625.000 |
Tijdlijn
Startdatum | 1-4-2023 |
Einddatum | 31-3-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUMpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Cross-species Regulation of Action by Controllability: a Keystone of 5-HT signalling?This project aims to investigate the role of serotonin neurons in controllability estimation and its impact on behavior in health and depression, using advanced computational and neuroimaging techniques. | ERC Starting... | € 1.483.738 | 2023 | Details |
Combinatorial neuromodulation of internal statesThis project aims to investigate how combinations of neuromodulators influence neuronal dynamics and circuit configurations in the hippocampus-prefrontal circuit during various behavioral states in mice. | ERC Starting... | € 1.499.563 | 2025 | Details |
Cease or Persist: A multivariate mechanistic account of effortful persistenceThe COPE project aims to develop a neuro-computational model of effortful persistence to understand decision-making in neuropsychiatric disorders and improve treatment personalization. | ERC Starting... | € 1.500.000 | 2025 | Details |
Neuromodulatory control of brain network dynamicsThis project aims to uncover the physiological mechanisms of spontaneous brain network dynamics in awake mice through advanced neuromodulation techniques, with implications for neuroscience. | ERC Consolid... | € 1.999.438 | 2025 | Details |
Feedback-control of the Microenvironment: Modular Organ-on-Chip Technology to elucidate the role of Neurovascular Stress in SchizophreniaCHIPzophrenia aims to develop a feedback-controlled organ-on-chip system to study nitrosative stress effects on the blood-brain barrier, enhancing in-vitro research for schizophrenia and related disorders. | ERC Starting... | € 1.499.375 | 2024 | Details |
Cross-species Regulation of Action by Controllability: a Keystone of 5-HT signalling?
This project aims to investigate the role of serotonin neurons in controllability estimation and its impact on behavior in health and depression, using advanced computational and neuroimaging techniques.
Combinatorial neuromodulation of internal states
This project aims to investigate how combinations of neuromodulators influence neuronal dynamics and circuit configurations in the hippocampus-prefrontal circuit during various behavioral states in mice.
Cease or Persist: A multivariate mechanistic account of effortful persistence
The COPE project aims to develop a neuro-computational model of effortful persistence to understand decision-making in neuropsychiatric disorders and improve treatment personalization.
Neuromodulatory control of brain network dynamics
This project aims to uncover the physiological mechanisms of spontaneous brain network dynamics in awake mice through advanced neuromodulation techniques, with implications for neuroscience.
Feedback-control of the Microenvironment: Modular Organ-on-Chip Technology to elucidate the role of Neurovascular Stress in Schizophrenia
CHIPzophrenia aims to develop a feedback-controlled organ-on-chip system to study nitrosative stress effects on the blood-brain barrier, enhancing in-vitro research for schizophrenia and related disorders.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulationMETA-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders. | EIC Pathfinder | € 2.987.655 | 2024 | Details |
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation
META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.